ANGE-S004

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameANGE-S004

Drug Alias Namehuman neural stem cell therapy (Shanghai Angecon Biotechnology)ANGE-S004

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Neural stem cell therapyCell and gene therapy > Cell therapy > Stem cell therapy > Neurogenic potential stem cell therapy

Mechanisms of ActionNeuroprotectants

TargetsUpdating

Therapy Area/IndicationsAlzheimer Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaPending

Originator CompaniesShanghai Angecon Biotechnology Corp

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesShanghai Angecon Biotechnology Corp

Active IndicationsN/A

Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A